Does Pre-Therapy PSA Influence 177Lu-PSMA-617 Treatment Outcomes?

被引：0
|
作者：
Fermawi, S. [1 ]
Buehner, T. [1 ]
Kalarn, S. [2 ]
Sabottke, C. [2 ]
Recio-Boiles, A. [3 ]
Savir-Baruch, B. [1 ]
机构：
[1] Univ Arizona, Div Nucl, Dept Med Imaging, Coll Med Tucson, Tucson, AZ USA
[2] Univ Arizona, Coll Med Tucson, Dept Med Imaging, Tucson, AZ USA
[3] Univ Arizona, Coll Med Tucson, Dept Med Hematol & Med Oncol, Tucson, AZ USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-767
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [41] Value of Post-Therapy Quantitative SPECT for Monitoring Response to 177Lu-PSMA-617 Therapy
    Meyer, Catherine
    Yilmaz, Burcak
    Szidonya, Laszlo
    Winters, Celeste
    Mench, Anna
    Mallak, Nadine
    Mittra, Erik
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [42] Cocktail Therapy of 177Lu-PSMA-617 and 177Lu-EDTMP in Patients With mCRPC A Proof-of-Principle Application
    Bal, Chandrasekhar
    Yadav, Madhav Prasad
    Ballal, Sanjana
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (08) : E386 - E387
  • [43] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
  • [44] 177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer
    von Eyben, Finn E.
    Kiljunen, Timo
    Joensuu, Timo
    Kairemo, Kalevi
    Uprimny, Christian
    Virgolini, Irene
    ONCOTARGET, 2017, 8 (39) : 66112 - 66116
  • [45] Whole-Body Dosimetry in Therapy of Metastatic Prostate Cancer with 177Lu-PSMA-617
    Happel, C.
    Voeller, L.
    Kranert, W. T.
    Groener, D.
    Bockisch, B.
    Mader, N.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S695 - S695
  • [46] 177Lu-PSMA-617 Radioligand Therapy in Patient With Prostate Cancer Sciatic Nerve Metastasis
    Tonnelet, David
    Edet-Sanson, Agathe
    Augusto, Laetitia
    Cabourg, Marine
    Thureau, Sebastien
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (12) : E668 - E669
  • [47] Fractionated 177Lu-PSMA-617 therapy with 101 GBq in a patient with metastatic prostate cancer
    Happel, C.
    Wichert, J.
    Kranert, W. T.
    Voeller, L.
    Bockisch, B.
    Groener, D.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S697 - S697
  • [48] First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer
    Thomas J. W. Klein Nulent
    Robert J. J. van Es
    Stefan M. Willems
    Arthur. J. A. T. Braat
    Lot A. Devriese
    Remco de Bree
    Bart de Keizer
    EJNMMI Research, 11
  • [49] First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer
    Nulent, Thomas J. W. Klein
    van Es, Robert J. J.
    Willems, Stefan M.
    Braat, Arthur J. A. T.
    Devriese, Lot A.
    de Bree, Remco
    de Keizer, Bart
    EJNMMI RESEARCH, 2021, 11 (01)
  • [50] Hematotoxicity after Radioligand Therapy with 177Lu-PSMA-617 in Patients with Metastastic Prostate Cancer
    Groener, Daniel
    Baumgarten, Justus
    Davis, Karen
    Happel, Christian
    Ngoc, Christina Nguyen
    Wichert, Jennifer
    Mader, Nicolai
    Mandel, Philipp
    Nikolaos, Tselis
    Gruenwald, Frank
    Sabet, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345